title: Hemojuvelin hemochromatosis receiving iron chelation therapy with deferasirox: improvement of liver disease activity, cardiac and hematological function.
authors.forename: Takashi
authors.initials: T
authors.lastname: Maeda
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Nakamaki
authors.forename: Bungo
authors.initials: B
authors.lastname: Saito
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Nakashima
authors.forename: Hirotsugu
authors.initials: H
authors.lastname: Ariizumi
authors.forename: Kouji
authors.initials: K
authors.lastname: Yanagisawa
authors.forename: Ai
authors.initials: A
authors.lastname: Hattori
authors.forename: Yasuaki
authors.initials: Y
authors.lastname: Tatsumi
authors.forename: Hisao
authors.initials: H
authors.lastname: Hayashi
authors.forename: Kenshi
authors.initials: K
authors.lastname: Suzuki
authors.forename: Shigeru
authors.initials: S
authors.lastname: Tomoyasu
mesh_terms: D000328:Adult; D001565:Benzoates / Q000627:therapeutic use*; D000077588:Deferasirox; D058851:GPI-Linked Proteins / Q000378:metabolism*; D006334:Heart Function Tests; D006432:Hemochromatosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D000071020:Hemochromatosis Protein; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008111:Liver Function Tests; D008297:Male; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D001565:Benzoates; D058851:GPI-Linked Proteins; C481006:HJV protein, human; D000071020:Hemochromatosis Protein; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox